Top Markets
Coin of the day
Q BioMed Inc. Q BioMed Inc.

Q BioMed Inc.

QBIO
Classement en actions #41615
Q BioMed Inc. functions as a biomedical accelerator and developer, actively... Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portfolio includes Metastron (Strontium Chloride SR89), a radiopharmaceutical designed to alleviate pain associated with metastatic bone cancer. Additionally, Q BioMed is advancing a pipeline of therapeutic candidates, including Man-01, a pre-clinical compound aimed at primary open-angle glaucoma; QBM-001, intended for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, which targets liver cancer. The company also collaborates with Mannin Research Inc. on the development of treatments for conditions such as acute respiratory distress syndrome, glaucoma, and various kidney diseases. Incorporated in New York, New York, in 2013, the entity was initially named ISMO Tech Solutions, Inc. before adopting its current name, Q BioMed Inc., in July 2015.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-04-02
Capitalisation boursière
$14.51K
Changement (1 jour)
0.00%
Changement (1 an)
9,900.00%
Pays
US
Échange Q BioMed Inc. (QBIO)

Catégorie

Historique des divisions d’actions pour Q BioMed Inc. (QBIO)
L’action Q BioMed Inc. (symbole : QBIO) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 13, 2026.
Une action QBIO achetée avant le Aug 13, 2026 équivaudrait aujourd’hui à 0 actions QBIO.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR